Forever young: the business of longevity drugs
The success of GLP-1s has prompted biotechs to approach the challenge differently. After years of false starts and disappointing results, longevity drugs could be on the horizon. Do immigrants from so...
5 Nov 23min
Not in Kansas any more: Republicans get a thrashing
In the end, the result was clear and uncontested: Democrats had an astonishingly good night. Our editors and correspondents across America report on the proceedings, and we ask what comes next—for Dem...
4 Nov 21min
Fertile ambitions: scientists’ plans to slow the biological clock
Two European startups are tackling the chromosomal abnormalities that make it difficult for older women to get pregnant. Their innovations might also prevent younger women from miscarrying. Belarusian...
3 Nov 21min
Off to the races: our American-midterms preview
Ahead of tomorrow’s legislative elections we consider the chances of a “blue wave”, the most influential demographics this time around and whether to expect election-administration trouble. Young peop...
2 Nov 24min
Silver-year strongman: 25 years of Narendra Modi
We examine the record of the man at the helm of India’s government. As protests pose a fresh threat, where will he take the country next? From New Hampshire to Virginia, our American-midterms series t...
30 Okt 27min
Effective non-altruism: Elon Musk’s foundation
The world’s richest person does not say much nice about philanthropy, and his foundation does not say much about itself. Our correspondent digs deeper. The next stop for our midterm-elections series i...
29 Okt 23min
Bye bye Bibi? Israel’s election results
Binyamin Netanyahu has underperformed but so has his main opponent, Gadi Eisenkot. Who will form a government? We decipher what the messy results mean for Israel. Our American-midterms series heads so...
28 Okt 21min
Act of Claude: Anthropic’s IPO bid
It would be the first public listing from a frontier-AI firm—and perhaps the largest IPO of all time. We comb through the filing to understand how the company is thinking about itself and its industry...
27 Okt 23min
